CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

Abstract The CRISPR/Cas9 system is an RNA-based adaptive immune system in bacteria and archaea. Various studies have shown that it is possible to target a wide range of human genes and treat some human diseases, including cancers, by the CRISPR/Cas9 system. In fact, CRISPR/Cas9 gene editing is one o...

Full description

Bibliographic Details
Main Authors: Mostafa Vaghari-Tabari, Parisa Hassanpour, Fatemeh Sadeghsoltani, Faezeh Malakoti, Forough Alemi, Durdi Qujeq, Zatollah Asemi, Bahman Yousefi
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Cellular & Molecular Biology Letters
Subjects:
CRISPR/Cas9
Gene editing
Chemoresistance
Malignancy
Cancer treatment
Online Access:https://doi.org/10.1186/s11658-022-00348-2

Internet

https://doi.org/10.1186/s11658-022-00348-2

Similar Items